Mostrar el registro sencillo del ítem
Correlación entre los anticuerpos Anti Citrulinados Cíclicos (ANTI–CCP) y la severidad del daño radiológico en pacientes con artritis reumatoide
dc.contributor.author | Sánchez Victoria, María Fernanda | |
dc.contributor.author | Castro Domínguez, Juliana | |
dc.contributor.author | Londoño Patiño, John Darío | |
dc.contributor.author | Granados, Carlos Eduardo | |
dc.date.accessioned | 2011-09-09T19:01:20Z | |
dc.date.available | 2011-09-09T19:01:20Z | |
dc.date.issued | 2011-09-09 | |
dc.identifier.citation | Sommer O. Kladosek A. Weiler V. Czembirek H. Boeck M. Stiskal M. Rheumatoid Arthritis. A Practical Guide to State-of-the-Art Imaging, Image Interpretation, and Clinical Implications. RadioGraphics. 2005; 25 (2): 381-398. | |
dc.identifier.citation | Resnick D. Artritis Reumatoide y espondiloartropatías seronegativas: características radiológicas y patológicas, en Resnick D. Huesos y Articulaciones en Imagen. 2da edición. Madrid. Marban 2001, 195. | |
dc.identifier.citation | Lipsky P. Why Does Rheumatoid Arthritis Involve the Joint. N Engl J Med. 2007; 356: 2419-2420. | |
dc.identifier.citation | Panayi GS. Corrigall VM. Pitzalis C. Pathogenesis of rheumatoid arthritis: the role of T cells and other beasts. Rheum Dis Clin North Am. 2001; 27:317–334 | |
dc.identifier.citation | Wick M C. Lindblad S. Weiss R J. Klareskog L. Van Vollenhoven R F. Estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid arthritis. Ann Rheum Dis. 2005;64:134-137 | |
dc.identifier.citation | Calvo E. Villarraga A. Imágenes diagnósticas en artritis reumatoide. Med UNAB. 2006; 9:108-119. | |
dc.identifier.citation | Ory PA. Interpreting radiographic data in rheumatoid arthritis. Ann Rheum Dis.2003; 62:597-604 | |
dc.identifier.citation | Brower AC. Radiographic assessment of disease progression in rheumatoid arthritis. Rheum Dis Clin North Am. 1991; 17:471–85 | |
dc.identifier.citation | Harris ED. Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med. 1990; 322:1277–1289. | |
dc.identifier.citation | Scott DL. Pugner K. Kaarela K. Doyle DV. Woolf A. Holmes J. “et al”. The links between joint damage and disability in rheumatoid arthritis. Rheumatology 2000; 39:122–132 | |
dc.identifier.citation | Lassere MN. Van der Heijde D. Johnson KR. Boers M. Edmonds J. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials. J Rheumatol. 2001; 28:892–903 | |
dc.identifier.citation | Hulsmans HM. Jacobs JWG. Van der Heijde D. Van Albada-Kuipers GA. Schenk Y. Bijlsma JWJ. The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum. 2000;43:1927–40. | |
dc.identifier.citation | Brook A. Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis. 1977; 36:71–3. | |
dc.identifier.citation | Van der Heidje D. How To Read Radiographs according to the Shar- van der Heidje method. J of rheumetol. 1999; 26: 743-745 | |
dc.identifier.citation | Boini S. Guillemin F. Radiographics scoring methods as outcome measures in rheumatoid arthritis properties and advantages. Ann Rheum Dis. 2001; 60: 817-827 | |
dc.identifier.citation | Van de Stadt RJ. Aarden L. Dijkmans BAC. Hamann D. Nielen MMJ. Van der Horst AR. “et al”. Antibodies to citrullinated humafibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann Rheum Dis. 2005; 64; 1199-1204. | |
dc.identifier.citation | Lindqvist E. Eberhardt K. Bendtzen K. Heinegård D. Saxne T. Prognostic laboratory markers of joint damage in arthritis rheumatoid. Ann Rheum Dis. 2005; 64:196-201. | |
dc.identifier.citation | Ávila LM. Londoño JD. Cardona A. Salazar JC. Santos AM. Romero C. “et al”. Valores de referencia de los anticuerpos anti-citrulina IgG, e isotipos IgG e IgA del factor reumatoide en un grupo de individuos del Hospital Militar Central. Revista Colombiana de Reumatologia. 2004; 11(3):201-208. | |
dc.identifier.citation | Van Venrooi WJ. Pruijn GJM. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2000; 2:249–251. | |
dc.identifier.citation | Song YW. Kang EH. Autoantibodies in rheumatoid arthritis: Rheumaroid factors and anticitrullinated protein antibodies. Q J med 2010; 103:139-146. | |
dc.identifier.citation | Mittermayer S.Murray B. Kiyomitsu M.”et all” a comparasion of the frecuency of antibodies to cyclic citrullinated peptid using a third generation anti cpp assay (cpp3) in systemic sclerosis, primary cirriosis and rheumatoid anthritis. Clin Rheumatol 2008; 27:77-83. | |
dc.identifier.citation | Boinni S. Guillemin F. Radiographic scoring methods as outcome measure in rhuematoid arthrithis: properties and advantages. Ann Rheum Dis. 2001; 60:817-827 | |
dc.identifier.citation | Vossenaar ER. Zendman AJ. Van Venrooij WJ. Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis. Arthritis Res Ther 2004;6:1-5. | |
dc.identifier.citation | Aho K. Heliovaara M. Maatela J. Tuomi T.Palusuo T. Rheuma- toid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991; 18:1282– 4. | |
dc.identifier.citation | Aho K. Von Essen R. Kurki P. Palusuo T. Heliovaara M. Antik- eratin antibody and antiperinuclear factor as markers for subclin- ical rheumatoid disease process. J Rheumatol 1993; 20:1278–81. | |
dc.identifier.citation | Nielen MM. van Schaardenburg D. Reesink HW. van de Stadt RJ. van der Horst-Bruinsma IE. de Koning MM. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004;50:380–6 | |
dc.identifier.citation | Klarenbeek N B. Güler-Yüksel M. van der Heijde D M F M. Kerstens P J S M ¨et all¨ A comparison between the simplified erosion and narrowing score and the Sharp–van der Heijde score: post hoc analysis from the BeSt study Ann Rheum Dis 2011;70:714-716 | |
dc.identifier.citation | Bland JM. Almant DG. Comparting methods of measurement: why plotting diference against standard method is misleading. Lancet 1995 346; 1085-7 | |
dc.identifier.citation | Van der Heidje D. Danker T. NIeman F. et al reliability and senetittibity to change of simplification of Sahrp/van der Heidje radiological assesment in rheumatoid arthritis.Rheumatology 1999 ; 38 : 941 | |
dc.identifier.citation | Aletaha D. Neogi T.Silman AJ. JFunovits J. Felson D. Bingham C. Birnbaum N. Burmester GR. “et al”. 2010 Rheumatoid Arthritis Classification Criteria. Arthritis Rheum. 2010; 62(9):2569-2581. | |
dc.identifier.citation | Weinblatt ME.Kremer JM. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving metothrexate. N Engl J Med 1999; 340: 253-259 | |
dc.identifier.citation | Ronnelid J. Wick MC.Lampa J. Lindbland Nordmark ´´et al´´ longuitudinal analysis of citrullinated protein/peptide antibodies (anti-cpp) during 5 year follow up in early rheumatoid arthritis: anti-cppstatus predicts worse disease activit and greater radiology progession. Ann Rheum Dis 2005;64:1744-1749 | |
dc.identifier.citation | Luna R. Concordancia intra e interobservador del método de Sharp-Van der Heijde tesis trabajo de grado. Bogotá Universidad Nacional de Colombia 2010. Tesis de grado no publicada. | |
dc.identifier.uri | http://hdl.handle.net/10818/198 | |
dc.description.abstract | En la actualidad, el diagnóstico de la AR se basa en los criterios diagnósticos y clasificatorios del Colegio Americano de Reumatología (CAR) en los cuales se incluye la presencia del Factor Reumatoide (FR), los anticuerpos anticitrulinados cíclicos( anti- ccp) e imágenes diagnósticas. En este articulo determinamos si los niveles de Anti ccp se relacionan con mayor daño en las articulaciones, evaluado por medio del método Sharp/Van der Heijde, considerando que si se demuestra la relación se podría influir en el curso de la enfermedad, instaurando oportunamente el tratamiento y disminuyendo los costos socioeconómicos que conlleva la condición comorbida. | es_CO |
dc.language.iso | spa | es_CO |
dc.subject | Antígenos | es_CO |
dc.subject | Artritis reumatoide | es_CO |
dc.title | Correlación entre los anticuerpos Anti Citrulinados Cíclicos (ANTI–CCP) y la severidad del daño radiológico en pacientes con artritis reumatoide | es_CO |